Related Experiment Videos
Absence of hepatitis B surface antigenemia after vaccination
W N Katkov1, M J Ault, S B Dubin
1Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048-0750.
Archives of Pathology & Laboratory Medicine
|November 1, 1989
Summary
Hepatitis B vaccination is safe and effective. Studies show that detectable hepatitis B surface antigenemia does not occur in individuals recently vaccinated, ruling out vaccination as a cause.
Area of Science:
- Hepatitis B research
- Vaccinology
- Immunology
Background:
- Hepatitis B vaccination is a key public health intervention.
- Available vaccines utilize hepatitis B surface antigen (HBsAg).
- Concerns exist regarding potential HBsAg detection post-vaccination.
Purpose of the Study:
- To investigate whether recent hepatitis B vaccination leads to detectable HBsAg in the blood.
- To determine if vaccination is a source of false-positive HBsAg results.
Main Methods:
- Utilized two current immunoassays for HBsAg detection.
- Collected blood samples from individuals at 1 hour and 24 hours post-vaccination.
- Analyzed samples for the presence of HBsAg.
Main Results:
- Hepatitis B surface antigen (HBsAg) was not detected in any blood samples.
- No detectable HBsAg was observed at either the 1-hour or 24-hour time points after vaccination.
Conclusions:
- Recent hepatitis B vaccination does not result in detectable HBsAg.
- The presence of HBsAg in blood cannot be attributed to recent immunization.